Gopal Rao | Global Business Development and Services Outsourcing
Biotech Division Lupin Ltd | India

Gopal Rao, Global Business Development and Services Outsourcing, Biotech Division Lupin Ltd

Gopal Rao is part of the Global BD and Licensing team at Lupin Biotech based out of the Biotech Division of Lupin at Pune, India, responsible for product evaluation, commercial launch strategy, Evaluating and finalizing B2B licensing partners in Japan and Emerging markets along with liaising with the US BD and EU BD team for partnering support. Also looking at all vendor negotiations and outsourcing activities at Lupins Biotech division. With a pipeline of over 11 Biosimilars at various stages of development, Lupin Biotech is geared up to become one of the names to recon with in the Biosimilar industry globally.

With over ten years of experience in the Biosimilar space in companies like Biocon Limited and Lupin Limited, he has a good insight and detailed thought process towards Biosimilar development and commercialization strategy globally.


Conference Day 1 @ 16:30

Overcoming challenges of bringing biosimilars to market

As the pharma market in India shifts from generics to biosimilars production, more and more players are entering the biosimilars market and competition is becoming stiff. In order to overcome the competition, Pharma has to ensure that they produce the products cheaper and faster. How can they do that?
  • How can Pharma reduce the cost of production?
  • What are some cutting edge technologies presently available to help manage the cost?
  • Are there capital and infrastructure investments that can be made to save cost in the long run?

back to speakers